2025-07-24 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc (UNH) based on the data you provided. The report is structured to provide a clear picture of the company's performance, recent market activity, and future potential.

**Report: UnitedHealth Group Inc (UNH) Analysis**

**1. Relative Performance vs. S&P 500 (VOO)**

*   **Ticker:** UNH
*   **Company:** UnitedHealth Group Inc. is a diversified healthcare company providing a wide range of products and services.
*   **UNH Cumulative Return:** 13.09%
*   **VOO Cumulative Return:** 97.07%
*   **Performance Differential:**
    *   **Current Difference:** -84.0
    *   **Min/Max Range:** (-85.2, 55.3)
    *   **Relative Difference (0-100):** 0.9

**Analysis:** UNH has significantly underperformed the S&P 500 (VOO) over the tracked period. The current difference is -84.0, positioning it near the lower end of its historical performance range relative to the index (relative difference of 0.9).

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha   | Beta  | Cap(B) |
|------------|----------|----------|---------|-------|--------|
| 2015-2017  | 65.0%    | 56.6%    | 36.0%   | 0.0   | 202.0  |
| 2016-2018  | 52.0%    | 63.7%    | 34.0%   | 0.0   | 228.2  |
| 2017-2019  | 38.0%    | 63.7%    | 9.0%    | 0.3   | 269.4  |
| 2018-2020  | -21.0%   | 63.7%    | -40.0%  | 0.4   | 321.3  |
| 2019-2021  | 36.0%    | 61.0%    | -13.0%  | 0.4   | 460.1  |
| 2020-2022  | 28.0%    | 66.9%    | 26.0%   | 0.4   | 485.8  |
| 2021-2023  | 33.0%    | 67.5%    | 15.0%   | 0.4   | 482.4  |
| 2022-2024  | -31.0%   | 68.6%    | -57.0%  | 0.3   | 463.5  |
| 2023-2025  | -63.0%   | 75.7%    | -112.0% | 0.2   | 261.2  |

**Analysis:**  The table shows a decline in UNH's performance in recent years.

*   **CAGR:** The Compound Annual Growth Rate (CAGR) has deteriorated in recent periods, with negative growth in the most recent years (2022-2025).
*   **MDD:** Maximum Drawdown (MDD) has increased over time, indicating greater potential losses from peak to trough.
*   **Alpha:** Alpha, which measures excess return relative to the benchmark, is sharply negative in the later periods, especially from 2022 onwards. This indicates significant underperformance compared to the market.
*   **Beta:** The Beta values are relatively low (0.0 to 0.4), suggesting that UNH has generally been less volatile than the market, though this benefit hasn't translated into positive relative returns recently.
*   **Cap(B):** Market capitalization generally increased until recently but has significantly declined in the last reported period. This reduction in market capitalization may reflect investor concern over the company's recent performance.

**2. Recent Price Action**

*   **Current Price:** 285.13
*   **Last Market Data:**
    *   **Price:** 287.9
    *   **Previous Close:** 285.13
    *   **Change:** 0.97
*   **Moving Averages:**
    *   **5-day MA:** 286.096
    *   **20-day MA:** 300.4527
    *   **60-day MA:** 321.6198

**Analysis:** UNH is trading below its 5, 20, and 60-day moving averages, indicating a downward trend. The recent price increase (change of 0.97) suggests a possible short-term rebound, but it remains to be seen if this will reverse the overall negative trend.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3359 (Low Risk)
*   **RSI:** 16.16 (Oversold)
*   **PPO:** -0.368
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Difference Change:** 0.9 (+) (Short-term increase)
*   **Expected Return:** 1114.9%

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests a low-risk environment, but this may not be specific to UNH.
*   **RSI:** The Relative Strength Index (RSI) is at 16.16, indicating that the stock is heavily oversold and may be due for a short-term bounce.
*   **PPO:** The Percentage Price Oscillator (PPO) is negative (-0.368), confirming the downtrend.
*   **Hybrid Signal:** The hybrid signal is advising to buy 80% with the existing cash, but has a caution for MRI(0.33)
*   **Recent (20-day) Relative Difference Change:** The relative difference has an increase, so the trend could change
*   **Expected Return:** The incredibly high expected return (1114.9%) should be viewed with extreme skepticism. It's likely based on an overly optimistic model or flawed data. It suggests significant outperformance versus the S&P 500 if investing long-term.

**4. Recent News & Significant Events**

*   **2025-07-23:** Major business developments, regulatory changes, or market events impacting UNH.
*   **2025-07-22:** Analyst discussions on UNH's performance in the context of industry trends and global economic factors.
*   **2025-07-21:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-20:** Market experts highlighting both risks and opportunities.

**Analysis:** The recent news indicates that UNH is subject to significant external factors, which can affect UNH. Pay close attention to the news to invest in UNH.

**5. Recent Earnings Analysis**

| 날짜         | EPS    | 매출        |
|--------------|--------|-------------|
| 2025-05-07   | 6.9    | 109.58 B$   |
| 2024-11-04   | 6.56   | 100.82 B$   |
| 2024-08-09   | 4.58   | 98.86 B$    |
| 2024-05-09   | -1.53  | 99.80 B$    |
| 2025-05-07   | -1.53  | 99.80 B$    |

**Analysis:**
* Revenue has increased in the most recent quarter, which is a positive indicator.
* EPS was negative for two consecutive periods and sharply increased to 6.9 in 2025-05-07
* Because 2025-05-07 is duplicated, one should be removed

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-03-31   | $109.58B   | 21.70%        |
| 2024-12-31   | $100.81B   | 21.14%        |
| 2024-09-30   | $100.82B   | 22.84%        |
| 2024-06-30   | $98.86B    | 22.31%        |
| 2024-03-31   | $99.80B    | 23.05%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE     |
|--------------|------------|---------|
| 2025-03-31   | $95.04B    | 6.62%   |
| 2024-12-31   | $92.66B    | 5.98%   |
| 2024-09-30   | $94.53B    | 6.41%   |
| 2024-06-30   | $89.36B    | 4.72%   |
| 2024-03-31   | $86.69B    | -1.63%  |

**Analysis:**

*   **Revenue:** Revenue has been generally increasing over the quarters, indicating positive sales growth.
*   **Profit Margin:** Profit margins have remained relatively consistent.
*   **Equity:** Total equity has been trending upwards, suggesting that the company's net worth is growing.
*   **ROE:** Return on Equity (ROE) shows that the return on invested capital increased substantially from -1.63% to 6.62%.

**7. Overall Conclusion**

UNH has significantly underperformed the S&P 500 recently, and the price has been declining due to external factors that affected UNH. Although Recent financial information shows that the profit margin and equity has improved compared to previous years, it is too early to say it can continue. The hybrid signal is advising to buy 80% with the existing cash, but has a caution for MRI(0.33). The relative difference has an increase, so the trend could change. Therefore, close attention to company's upcoming news is required, and consider short-term invest, if proceed to invest.

**Disclaimer:** This analysis is based solely on the provided data and does not constitute financial advice. Any investment decisions should be made after consulting with a qualified financial advisor and conducting thorough due diligence.
